North America Blood-based Biomaker For Sports Medicine Market Size & Outlook
North America blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
North America blood-based biomaker for sports medicine market highlights
- The North America blood-based biomaker for sports medicine market generated a revenue of USD 292.5 million in 2023.
- The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 292.5 million |
| Market revenue in 2030 | USD 511.0 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, North America region accounted for 43.9% of the global blood-based biomaker for sports medicine market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 259.9 million by 2030.
Ck was the largest segment with a revenue share of 18.02% in 2023. Horizon Databook has segmented the North America blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
As athletes and sports organizations increasingly prioritize precise health monitoring, the demand for advanced biomarkers to detect early signs of injuries and optimize recovery is expected to grow. According to a report published by Nature in April 2021, injury rates in professional sports are notably high, with incidents reported at 3.61 per 1,000 athlete exposures in baseball, 19.3 in basketball, 64.7 in football, and 49.4 in ice hockey.
The market benefits from technological advancements in biomarker analysis and a greater emphasis on personalized medicine. With a robust sports culture and a strong healthcare infrastructure, North America leads in integrating these biomarkers into routine athletic care.
In addition, this growth is supported by the need for efficient recovery strategies and enhanced performance monitoring, which are crucial for professional & amateur athletes. As awareness and adoption increase, the market is projected to witness significant growth over the coming decade.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America blood-based biomaker for sports medicine market size, by country, 2018-2030 (US$M)
North America Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
